![Rebecca Taub](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rebecca Taub
Fondateur chez
MADRIGAL PHARMACEUTICALS, INC.
Fortune : 545 M $ au 31/05/2026
Profil
Dr. Rebecca A. Taub, MD, is an Independent Director at BriaCell Therapeutics Corp.
She is on the Board of Directors at BriaCell Therapeutics Corp.
and Madrigal Pharmaceuticals, Inc. Dr. Taub was previously employed as a Chief Executive Officer & Director by Madrigal Pharmaceuticals, Inc. /Old/, a Senior Vice President-Research & Development by VIA Pharmaceuticals, Inc., a Vice President-Research & Metabolic Diseases by Hoffmann-La Roche, Inc., a Vice President-Research by Roche Pharmaceuticals, Inc., an Executive Director-CNS & Obesity Research by Bristol Myers Squibb Co., an Executive Director-CNS & Obesity Research by DuPont Pharmaceuticals Co., a Professor by Perelman School of Medicine, a Professor by University of Pennsylvania, an Assistant Professor by Harvard Medical School, and an Associate Investigator by Howard Hughes Medical Institute, Inc. She received her undergraduate degree from Yale College and a doctorate degree from Yale School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/04/2026 | 1 096 574 ( 4,76 % ) | 545 M $ | 31/05/2026 | |
| 28/01/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Rebecca Taub
| Sociétés | Poste | Début |
|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | Fondateur | 10/03/2000 |
| BRIACELL THERAPEUTICS CORP. | Directeur/Membre du Conseil | 07/03/2019 |
Anciens postes connus de Rebecca Taub
| Sociétés | Poste | Fin |
|---|---|---|
| VIA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2011 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Directeur Technique/Scientifique/R&D | 01/01/2008 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2003 |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Provides researches and develops pharmaceuticals and imaging products to treat diseases | Corporate Officer/Principal | 01/01/2003 |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2002 |
Formation de Rebecca Taub
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
80
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Provides researches and develops pharmaceuticals and imaging products to treat diseases | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Howard Hughes Medical Institute, Inc.
 Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
VIA Pharmaceuticals, Inc.
 VIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops compounds for the treatment of cardiovascular and metabolic disease | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Madrigal Pharmaceuticals, Inc. /Old/
 Madrigal Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases | Health Technology |
Perelman School of Medicine
 Perelman School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale College
 Yale College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BriaCell Therapeutics Corp.
 BriaCell Therapeutics Corp. BiotechnologyHealth Technology Operates as an immuno-oncology biotechnology company which develops targeted approaches for the management of breast cancer | Health Technology |
Madrigal Pharmaceuticals, Inc.
 Madrigal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for cardiovascular, metabolic and liver diseases | Health Technology |
